DUBLIN, IRELAND--(Marketwire - March 26, 2008) - Trinity Biotech plc (NASDAQ: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced that Brendan Farrell, Chief Executive Officer, will be speaking at the B. Riley & Company 9th Annual Investor Conference in Las Vegas at 08:00 a.m. Pacific Time, on Thursday the 3rd of April. The event will be webcast and can be accessed on: http://www.wsw.com/webcast/brileyco9/trib/
